Karwowska, U.; Kudrycka, A.; Pierzchała, K.; Stawski, R.; Jerczyńska, H.; Białasiewicz, P.; Kuczyński, W.
Twelve-Month CPAP Therapy Modulates BDNF Levels in Patients with Severe Obstructive Sleep Apnea: Implications for Metabolic and Treatment Compliance. Int. J. Mol. Sci. 2025, 26, 5855.
https://doi.org/10.3390/ijms26125855
AMA Style
Karwowska U, Kudrycka A, Pierzchała K, Stawski R, Jerczyńska H, Białasiewicz P, Kuczyński W.
Twelve-Month CPAP Therapy Modulates BDNF Levels in Patients with Severe Obstructive Sleep Apnea: Implications for Metabolic and Treatment Compliance. International Journal of Molecular Sciences. 2025; 26(12):5855.
https://doi.org/10.3390/ijms26125855
Chicago/Turabian Style
Karwowska, Urszula, Aleksandra Kudrycka, Karol Pierzchała, Robert Stawski, Hanna Jerczyńska, Piotr Białasiewicz, and Wojciech Kuczyński.
2025. "Twelve-Month CPAP Therapy Modulates BDNF Levels in Patients with Severe Obstructive Sleep Apnea: Implications for Metabolic and Treatment Compliance" International Journal of Molecular Sciences 26, no. 12: 5855.
https://doi.org/10.3390/ijms26125855
APA Style
Karwowska, U., Kudrycka, A., Pierzchała, K., Stawski, R., Jerczyńska, H., Białasiewicz, P., & Kuczyński, W.
(2025). Twelve-Month CPAP Therapy Modulates BDNF Levels in Patients with Severe Obstructive Sleep Apnea: Implications for Metabolic and Treatment Compliance. International Journal of Molecular Sciences, 26(12), 5855.
https://doi.org/10.3390/ijms26125855
